Kevin Koch Edgewise Therapeutics, Inc. (EWTX) insider trading activity

Kevin Koch is President and CEO of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 30,615 shares of EWTX, which is worth approximately $409,934. The most recent transaction as insider was on Aug 12, 2025, when has been sold 7,972 shares (Common Stock) at a price of $13.39 per share, resulting in proceeds of $106,745. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.6K

48.48% 3M change

111.46% 12M change

Total Value Held $409,934

KEVIN KOCH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 12 2025	SELL Open market or private sale	$106,745 $13.39 p/Share	7,972 Reduced 20.66%	30,615 Common Stock
Aug 12 2025	BUY Exercise of conversion of derivative security	-	17,968 Added 31.77%	38,587 Common Stock
May 02 2025	SELL Open market or private sale	$70,340 $16.45 p/Share	4,276 Reduced 17.18%	20,619 Common Stock
May 01 2025	BUY Exercise of conversion of derivative security	-	10,417 Added 29.5%	24,895 Common Stock
Mar 07 2025	SELL Open market or private sale	$3,000 $30.0 p/Share	100 Reduced 0.69%	14,478 Common Stock
Mar 07 2025	BUY Exercise of conversion of derivative security	$18 $0.18 p/Share	100 Added 0.68%	14,578 Common Stock
Feb 06 2025	SELL Open market or private sale	$28,017 $31.13 p/Share	900 Reduced 5.85%	14,478 Common Stock
Feb 06 2025	BUY Exercise of conversion of derivative security	$11,799 $13.11 p/Share	900 Added 5.53%	15,378 Common Stock
Feb 05 2025	SELL Open market or private sale	$259,339 $30.03 p/Share	8,636 Reduced 37.36%	14,478 Common Stock
Feb 05 2025	BUY Exercise of conversion of derivative security	$1,554 $0.18 p/Share	8,636 Added 27.2%	23,114 Common Stock
May 02 2024	SELL Open market or private sale	$59,604 $18.91 p/Share	3,152 Reduced 17.88%	14,478 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	-	10,417 Added 37.14%	17,630 Common Stock
May 02 2023	SELL Open market or private sale	$28,506 $8.9 p/Share	3,203 Reduced 30.75%	7,213 Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	-	10,416 Added 50.0%	10,416 Common Stock

Kevin Koch

President and CEO

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Value

Insider Trading

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edgewise Therapeutics, Inc.

Track Activities on EWTX

Account